Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
GlobeNewswire
77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated
64% of narcolepsy type..